A detailed history of Arvest Trust CO N A transactions in Abb Vie Inc. stock. As of the latest transaction made, Arvest Trust CO N A holds 93,669 shares of ABBV stock, worth $16.2 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
93,669
Previous 97,417 3.85%
Holding current value
$16.2 Million
Previous $17.7 Million 9.43%
% of portfolio
1.06%
Previous 1.12%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $580,152 - $677,488
-3,748 Reduced 3.85%
93,669 $16.1 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $591,973 - $674,498
-3,704 Reduced 3.66%
97,417 $17.7 Million
Q4 2023

Jan 24, 2024

SELL
$137.6 - $154.97 $239,148 - $269,337
-1,738 Reduced 1.69%
101,121 $15.7 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $110,078 - $127,431
-824 Reduced 0.79%
102,859 $15.3 Million
Q2 2023

Aug 15, 2023

SELL
$132.51 - $164.9 $459,809 - $572,203
-3,470 Reduced 3.24%
103,683 $14 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $841,774 - $969,429
-5,821 Reduced 5.15%
107,153 $17.1 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $254,628 - $305,366
-1,841 Reduced 1.6%
112,974 $18.3 Million
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $625,821 - $717,775
4,663 Added 4.23%
114,815 $15.4 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $212,347 - $269,963
-1,543 Reduced 1.38%
110,152 $16.9 Million
Q1 2022

May 04, 2022

SELL
$131.98 - $163.75 $365,320 - $453,260
-2,768 Reduced 2.42%
111,695 $18.1 Million
Q4 2021

Mar 08, 2022

BUY
$107.43 - $135.93 $12.3 Million - $15.6 Million
114,463 New
114,463 $15.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Arvest Trust CO N A Portfolio

Follow Arvest Trust CO N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvest Trust CO N A, based on Form 13F filings with the SEC.

News

Stay updated on Arvest Trust CO N A with notifications on news.